vs
Side-by-side financial comparison of Largo Inc. (LGO) and Profusa, Inc. (PFSA). Click either name above to swap in a different company.
Largo Inc. is the larger business by last-quarter revenue ($87.6K vs $75.0K, roughly 1.2× Profusa, Inc.). Largo Inc. runs the higher net margin — -59.3% vs -3329.3%, a 3270.0% gap on every dollar of revenue.
Largo Inc. is a Canada-based critical minerals producer focused on sustainable vanadium extraction and processing. It operates core production assets in Brazil, supplying high-purity vanadium products for steel manufacturing, grid-scale energy storage, and industrial clients across global markets.
Profusa, Inc. is a biotechnology firm specializing in long-term implantable biosensor technology. Its products enable continuous real-time monitoring of multiple biological markers, serving core segments including clinical care, chronic disease management, medical research, and global digital health markets.
LGO vs PFSA — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2024
| Metric | | |
|---|---|---|
| Revenue | $87.6K | $75.0K |
| Net Profit | $-52.0K | $-2.5M |
| Gross Margin | — | — |
| Operating Margin | — | -1470.7% |
| Net Margin | -59.3% | -3329.3% |
| Revenue YoY | — | — |
| Net Profit YoY | — | -579.7% |
| EPS (diluted) | — | $-1.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $87.6K | — | ||
| Q2 25 | $54.4K | — | ||
| Q1 25 | $28.2K | — | ||
| Q3 24 | $100.7K | $75.0K | ||
| Q2 24 | $70.7K | — | ||
| Q1 24 | $42.2K | — |
| Q3 25 | $-52.0K | — | ||
| Q2 25 | $-40.0K | — | ||
| Q1 25 | $-18.3K | — | ||
| Q3 24 | $-18.7K | $-2.5M | ||
| Q2 24 | $-3.9K | — | ||
| Q1 24 | $715 | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | -1470.7% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q3 25 | -59.3% | — | ||
| Q2 25 | -73.6% | — | ||
| Q1 25 | -64.9% | — | ||
| Q3 24 | -18.6% | -3329.3% | ||
| Q2 24 | -5.6% | — | ||
| Q1 24 | 1.7% | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | $-1.29 | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $533 |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $-117.0M |
| Total Assets | — | $8.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | $533 | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | $-117.0M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | $8.8M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-1.2M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | $-1.2M | ||
| Q2 24 | — | — | ||
| Q1 24 | $5.0K | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 6.93× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
